Associations Between the Gut Microbiome, Gut Microbiology and Heart Failure: Current Understanding and Future Directions

Overview

Journal Am Heart J Plus

Specialty Cardiology & Vascular Diseases

Date 2024 Apr 1

PMID 38559891

Authors

Divyansh Sharma

Abhisheik Prashar

Affiliations

Soon will be listed here.

Abstract

The role of the gut microbiome in pathophysiology, prognostication and clinical management of heart failure (HF) patients is of great clinical and research interest. Both preclinical and clinical studies have shown promising results, and the gut microbiome has been implicated in other cardiovascular conditions that are risk factors for HF. There is an increasing interest in the use of biological compounds produced as biomarkers for prognostication as well as exploration of therapeutic options targeting the various markers and pathways from the gut microbiome that are implicated in HF. However, study variations exist, and targeted research for individual putative biomarkers is necessary. There is also limited evidence pertaining to decompensated HF in particular. In this review, we synthesize current understandings around pathophysiology, prognostication and clinical management of heart failure (HF) patients, and also provide an outline of potential areas of future research and scientific advances.

References

Israr M, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney L . Association of gut-related metabolites with outcome in acute heart failure. Am Heart J. 2021; 234:71-80. DOI: 10.1016/j.ahj.2021.01.006. View

Chen T, Kim C, Kaur A, Lamothe L, Shaikh M, Keshavarzian A . Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model. Food Funct. 2017; 8(3):1166-1173. DOI: 10.1039/c6fo01532h. View

Jin L, Shi X, Yang J, Zhao Y, Xue L, Xu L . Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell. 2020; 12(5):346-359. PMC: 8106559. DOI: 10.1007/s13238-020-00785-9. View

Moludi J, Saiedi S, Ebrahimi B, Alizadeh M, Khajebishak Y, Ghadimi S . Probiotics Supplementation on Cardiac Remodeling Following Myocardial Infarction: a Single-Center Double-Blind Clinical Study. J Cardiovasc Transl Res. 2020; 14(2):299-307. DOI: 10.1007/s12265-020-10052-1. View

Roberts E, Ludman A, Dworzynski K, Al-Mohammad A, Cowie M, McMurray J . The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 2015; 350:h910. PMC: 4353288. DOI: 10.1136/bmj.h910. View

Zhang Y, Wang Y, Ke B, Du J . TMAO: how gut microbiota contributes to heart failure. Transl Res. 2020; 228:109-125. DOI: 10.1016/j.trsl.2020.08.007. View

Wang X, Chen Z, Geng B, Cai J . The Bidirectional Signal Communication of Microbiota-Gut-Brain Axis in Hypertension. Int J Hypertens. 2021; 2021:8174789. PMC: 8714396. DOI: 10.1155/2021/8174789. View

Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A . Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015; 17(5):662-71. PMC: 4433427. DOI: 10.1016/j.chom.2015.03.005. View

Mayerhofer C, Ueland T, Broch K, Vincent R, Cross G, Dahl C . Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure. J Card Fail. 2017; 23(9):666-671. DOI: 10.1016/j.cardfail.2017.06.007. View

10.

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18):e895-e1032. DOI: 10.1161/CIR.0000000000001063. View

11.

Emoto T, Hayashi T, Tabata T, Yamashita T, Watanabe H, Takahashi T . Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure. Int J Cardiol. 2021; 338:138-142. DOI: 10.1016/j.ijcard.2021.06.003. View

12.

Maiuolo J, Carresi C, Gliozzi M, Mollace R, Scarano F, Scicchitano M . The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans. Int J Mol Sci. 2022; 23(7). PMC: 8999124. DOI: 10.3390/ijms23073698. View

13.

Branchereau M, Burcelin R, Heymes C . The gut microbiome and heart failure: A better gut for a better heart. Rev Endocr Metab Disord. 2019; 20(4):407-414. DOI: 10.1007/s11154-019-09519-7. View

14.

Parra-Izquierdo I, Bradley R, Aslan J . Platelets get gutted by PAG. Platelets. 2020; 31(5):618-620. PMC: 7332399. DOI: 10.1080/09537104.2020.1759793. View

15.

Tang W, Li D, Hazen S . Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol. 2018; 16(3):137-154. PMC: 6377322. DOI: 10.1038/s41569-018-0108-7. View

16.

Wang Z, Bergeron N, Levison B, Li X, Chiu S, Jia X . Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2018; 40(7):583-594. PMC: 6374688. DOI: 10.1093/eurheartj/ehy799. View

17.

Bohm M, Kario K, Kandzari D, Mahfoud F, Weber M, Schmieder R . Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020; 395(10234):1444-1451. DOI: 10.1016/S0140-6736(20)30554-7. View

18.

Piccioni A, Saviano A, Cicchinelli S, Franza L, Rosa F, Zanza C . Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak. Biomedicines. 2021; 9(9). PMC: 8468627. DOI: 10.3390/biomedicines9091234. View

19.

Madan S, Mehra M . Gut dysbiosis and heart failure: navigating the universe within. Eur J Heart Fail. 2020; 22(4):629-637. DOI: 10.1002/ejhf.1792. View

20.

Sharma D, Spring K, Bhaskar S . Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis. Acta Neurol Scand. 2021; 144(5):486-499. DOI: 10.1111/ane.13493. View